IIPLA News
Friday, May 1, 2026

India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI

, ETManufacturing Life Sciences 2 min read India supplies 20% of global generic medicines; its IP r…

IIPLA News Deskanonymous access0 articles left this week
India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

, ETManufacturing Life Sciences 2 min read India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI India maintains its intellectual property regime is compliant with international trade rules. This ongoing issue re…
Share This Article
Ready-to-post copy includes the article link.

India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI , ETManufacturing Life Sciences 2 min read India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI India maintains its intellectual property regime is compliant with international trade rules. T... Read the full IIPLA article: https://iipla.org/news/india-supplies-20-of-global-generic-medicines-its-ip-rules-wto-compliant-gtri

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Nigeria Advances Intellectual Property Reforms to Boost Economic Growth and Innovation

The Nigerian Federal Government is intensifying efforts to leverage intellectual property as a catalyst for economic development, investment, and job creation. Through collaboration with the World Intellectual Property Organization (WIPO) and the rollout of the Industrial Property Administration System (IPAS), Nigeria…

Thursday, May 28, 2026
PatentsGlobal

Procopio’s Patent Practice and Five Partners Earn Spots on 2026 IAM Patent 1000 List

Procopio’s patent prosecution team and five intellectual property partners have been named to the prestigious 2026 IAM Patent 1000 list. The recognition highlights the firm’s strengths in life sciences, AI, emerging technologies, and trade secrets, underscoring its integrated approach to patent portfolio development a…

Thursday, May 28, 2026